| 股號 / 名稱 | 營收 | 稅後淨利 |
| ABBV 艾伯維 | 14,460,000,000.0 | 1,564,000,000.0 |
| AZN AstraZeneca PLC | 13,565,000,000.0 | 1,433,000,000.0 |
| BMY 施貴寶 | 11,892,000,000.0 | 1,215,000,000.0 |
| AMGN 美國安進 | 8,503,000,000.0 | 2,830,000,000.0 |
| GILD 吉利德科學 | 7,545,000,000.0 | 1,253,000,000.0 |
| REGN 雷傑納榮製藥 | 3,720,700,000.0 | 1,340,600,000.0 |
| VRTX 福泰製藥 | 2,771,900,000.0 | 1,045,400,000.0 |
| BIIB Biogen Inc | 2,465,800,000.0 | 388,500,000.0 |
| MRNA 莫德納 | 1,862,000,000.0 | 13,000,000.0 |
| BNTX Biontech SE | 1,385,823,392.0 | 220,542,749.0 |
| INCY 英賽德 | 1,137,871,000.0 | 106,456,000.0 |
| ILMN Illumina Inc | 1,080,000,000.0 | 705,000,000.0 |
| BGNE Beigene Ltd | 1,001,599,000.0 | -121,350,000.0 |
| GMAB Genmab A/S | 827,731,400.0 | 189,153,060.0 |
| BMRN BioMarin Pharmaceutical Inc | 745,740,000.0 | 106,080,000.0 |
| EXAS Exact Sciences Corp | 708,655,000.0 | -38,236,000.0 |
| BIO.B Bio Rad Laboratories Inc | 649,729,000.0 | 653,172,000.0 |
| ARGX argenx SE | 573,236,000.0 | 91,410,000.0 |
| CVAC CureVac NV | 549,856,157.58 | 376,339,891.47 |
| EXEL Exelixis Inc | 539,542,000.0 | 117,973,000.0 |
| QGEN Qiagen NV | 501,869,000.0 | 98,056,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 500,919,000.0 | -111,570,000.0 |
| SRPT Sarepta Therapeutics Inc | 467,172,000.0 | 33,611,000.0 |
| ALKS Alkermes Plc | 378,143,000.0 | 92,795,000.0 |
| HCM HUTCHMED (China) Ltd | 305,681,000.0 | 26,165,000.0 |
| EBS Emergent BioSolutions Inc | 293,800,000.0 | 114,800,000.0 |
| HALO Halozyme Therapeutics Inc | 290,084,000.0 | 137,011,000.0 |
| TECH Bio-Techne Corp | 289,458,000.0 | 33,600,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 250,401,000.0 | 32,765,000.0 |
| MYGN Myriad Genetics Inc | 213,300,000.0 | -22,100,000.0 |
| APLS Apellis Pharmaceuticals Inc | 196,830,000.0 | -57,445,000.0 |
| GH Guardant Health Inc | 191,476,000.0 | -107,754,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 186,038,000.0 | 46,093,000.0 |
| ITCI Intra-Cellular Therapies Inc | 175,375,000.0 | -26,324,000.0 |
| NEO Neogenomics Inc | 167,824,000.0 | -17,699,000.0 |
| LEGN Legend Biotech Corp | 160,205,000.0 | -125,321,000.0 |
| RGEN Repligen Corp | 154,871,000.0 | -654,000.0 |
| ANIP ANI Pharmaceuticals Inc | 148,332,000.0 | -24,166,000.0 |
| FOLD Amicus Therapeutics Inc | 141,517,000.0 | -6,729,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 139,494,000.0 | -133,516,000.0 |
| BPMC Blueprint Medicines Corp | 128,184,000.0 | -56,276,000.0 |
| SVA Sinovac Biotech Ltd | 121,339,000.0 | -68,642,000.0 |
| ADMA ADMA Biologics Inc | 119,839,000.0 | 35,909,000.0 |
| KNSA Kiniksa Pharmaceuticals International PLC | 112,214,000.0 | -12,693,000.0 |
| MGNX MacroGenics Inc | 110,708,000.0 | 56,309,000.0 |
| AXSM Axsome Therapeutics Inc | 104,762,000.0 | -64,602,000.0 |
| ARVN Arvinas Inc | 102,400,000.0 | -49,200,000.0 |
| ZLAB Zai Lab Ltd | 102,265,000.0 | -41,671,000.0 |
| CERT Certara Inc | 94,820,000.0 | -1,371,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 93,761,000.0 | 37,037,000.0 |
| INSM Insmed Inc | 93,425,000.0 | -220,524,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 90,377,000.0 | -14,235,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 89,046,000.0 | -56,403,000.0 |
| CSTL Castle Biosciences Inc | 85,782,000.0 | 2,269,000.0 |
| TWST Twist Bioscience Corp | 84,710,000.0 | -34,655,000.0 |
| NVAX Novavax Inc | 84,512,000.0 | -121,300,000.0 |
| MDXG MiMedx Group Inc | 84,057,000.0 | 7,878,000.0 |
| TGTX TG Therapeutics Inc | 83,879,000.0 | 3,880,000.0 |
| KRYS Krystal Biotech Inc | 83,841,000.0 | 27,180,000.0 |
| DVAX Dynavax Technologies Corp | 80,630,000.0 | 17,594,000.0 |
| PBYI Puma Biotechnology Inc | 80,542,000.0 | 20,317,000.0 |
| PSTX Poseida Therapeutics Inc | 71,748,000.0 | 20,235,000.0 |
| CHRS Coherus BioSciences Inc | 70,774,000.0 | -10,751,000.0 |
| MNKD MannKind Corp | 70,079,000.0 | 11,550,000.0 |
| GLPG Galapagos NV | 66,629,293.21 | -54,072,495.3 |
| GNFT Genfit SA | 65,697,738.49 | 32,538,088.1 |
| MRVI Maravai LifeSciences Holdings Inc | 65,200,000.0 | -175,955,000.0 |
| ASND Ascendis Pharma A/S | 64,384,900.57 | -110,436,141.42 |
| TVTX Travere Therapeutics Inc | 62,898,000.0 | -54,752,000.0 |
| SANG Sangoma Technologies Corp | 60,150,000.0 | -1,910,000.0 |
| RVNC Revance Therapeutics Inc | 59,879,000.0 | -38,115,000.0 |
| IOVA Iovance Biotherapeutics Inc | 58,555,000.0 | -83,541,000.0 |
| VCEL Vericel Corp | 57,905,000.0 | -901,000.0 |
| IMTX Immatics NV | 56,286,829.11 | -9,540,895.3 |
| LGND Ligand Pharmaceuticals Inc | 51,812,000.0 | -7,172,000.0 |
| CTKB Cytek Biosciences Inc | 51,500,000.0 | 941,000.0 |
| SGMO Sangamo Therapeutics Inc | 49,412,000.0 | 10,672,000.0 |
| SWTX SpringWorks Therapeutics Inc | 49,301,000.0 | -53,530,000.0 |
| TARS Tarsus Pharmaceuticals Inc | 48,118,000.0 | -23,420,000.0 |
| RCUS Arcus Biosciences Inc | 48,000,000.0 | -92,000,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 47,651,000.0 | -5,324,000.0 |
| ADPT Adaptive Biotechnologies Corp | 46,435,000.0 | -32,097,000.0 |
| ARQT Arcutis Biotherapeutics Inc | 44,755,000.0 | -41,537,000.0 |
| ME 23andMe Holding Co. | 44,071,000.0 | -59,103,000.0 |
| AMRN Amarin Corporation PLC | 42,298,000.0 | -25,134,000.0 |
| KMDA Kamada Ltd | 41,740,000.0 | 3,863,000.0 |
| ARCT Arcturus Therapeutics Holdings Inc | 41,673,000.0 | -6,903,000.0 |
| ADAP Adaptimmune Therapeutics PLC | 40,901,000.0 | -17,617,000.0 |
| ATRA Atara Biotherapeutics Inc | 40,190,000.0 | -21,909,000.0 |
| ANIK Anika Therapeutics Inc | 38,753,000.0 | -29,918,000.0 |
| CDMO Avid Bioservices Inc | 33,482,000.0 | -17,406,000.0 |
| CTMX CytomX Therapeutics Inc | 33,432,000.0 | 5,736,000.0 |
| RYTM Rhythm Pharmaceuticals Inc | 33,251,000.0 | -43,641,000.0 |
| ACIU AC Immune SA | 30,309,310.5 | 6,544,717.9 |
| ANAB AnaptysBio Inc | 30,017,000.0 | -32,851,000.0 |
| GERN Geron Corp | 28,271,000.0 | -26,447,000.0 |
| ACLX Arcellx Inc | 26,030,000.0 | -25,867,000.0 |
| CDXC Chromadex Corp | 25,580,000.0 | 1,878,000.0 |
| URGN Urogen Pharma Ltd | 25,204,000.0 | -23,673,000.0 |
| AGEN Agenus Inc | 25,112,000.0 | -67,214,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰？
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例